Andrea N Lucas
Overview
Explore the profile of Andrea N Lucas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sundby R, Szymanski J, Pan A, Jones P, Mahmood S, Reid O, et al.
Clin Cancer Res
. 2024 Aug;
30(19):4363-4376.
PMID: 39093127
Purpose: Early detection of neurofibromatosis type 1 (NF1)-associated peripheral nerve sheath tumors (PNST) informs clinical decision-making, enabling early definitive treatment and potentially averting deadly outcomes. In this study, we describe...
2.
Sundby R, Szymanski J, Pan A, Jones P, Mahmood S, Reid O, et al.
medRxiv
. 2024 Jan;
PMID: 38293154
Early detection of neurofibromatosis type 1 (NF1) associated peripheral nerve sheath tumors (PNST) informs clinical decision-making, potentially averting deadly outcomes. Here, we describe a cell-free DNA (cfDNA) fragmentomic approach which...
3.
Lakhotia R, Dunleavy K, Abramson J, Link B, Powell B, Melani C, et al.
Blood Adv
. 2023 Jun;
7(18):5320-5324.
PMID: 37389844
No abstract available.
4.
Melani C, Dowdell K, Pittaluga S, Dunleavy K, Roschewski M, Song J, et al.
Lancet Haematol
. 2023 Apr;
10(5):e346-e358.
PMID: 37011643
Background: Lymphomatoid granulomatosis is a rare Epstein-Barr virus-associated B-cell lymphoproliferative disorder with a median overall survival of less than 2 years. In this study, we hypothesised that low-grade lymphomatoid granulomatosis...
5.
Roschewski M, Dunleavy K, Abramson J, Powell B, Link B, Patel P, et al.
J Clin Oncol
. 2020 May;
38(22):2519-2529.
PMID: 32453640
Purpose: Burkitt lymphoma is an aggressive B-cell lymphoma curable with dose-intensive chemotherapy derived from pediatric leukemia regimens. Treatment is acutely toxic with late sequelae. We hypothesized that dose-adjusted etoposide, doxorubicin,...